BHIL Q3 FY26: Cons PAT Rs 2,016 cr up 15%, 9M PAT Rs 7,062 cr up 47%

Revenue Growth 20pctPat Growth 25pctExceptional ItemResults View source PDF Explain this filing

BAJAJHLDNG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.5%Reaction day

₹10875.00

prior close

₹11000.00

announcement price

After-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)-0.5%+0.0% vs market

Holding Company peers, median of 12sector-0.3%-0.1% vs sector

On the reaction day the stock moved in line with Nifty 100 and 0.1 pts less than its Holding Company peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.8

10m

+1.2

15m

+0.5

30m

+1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.5-0.5+0.0-0.3-0.1

Next day

+1.1-0.3+1.5+0.1+1.0

+1.9+0.4+1.5+1.9+0.0

+1.6+0.6+1.0+2.6-1.0

+2.2+0.8+1.4+3.4-1.2

+1.3+0.2+1.1+1.6-0.2

+2.2-0.3+2.4+0.8+1.3

15d

+0.2-0.6+0.8-2.1+2.3

-1.9-3.6+1.8-7.4+5.5

-15.7-10.6-5.1-16.4+0.7

-3.6-5.3+1.6-5.0+1.3

UpDownMarket · Nifty 100Sector · Holding Company peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q3 FY26 cons PAT Rs 2,016 cr vs Rs 1,748 cr, up 15% YoY. 9M FY26 cons PAT Rs 7,062 cr vs Rs 4,795 cr, up 47%. Standalone 9M PAT surged to Rs 4,397 cr from Rs 1,201 cr, aided by Rs 1,983 cr exceptional gain from selling 1.04 cr BFS shares (Rs 2,002 cr block deal in June 2025). Excluding this one-off, 9M cons PAT grew about 18% to Rs 5,681 cr. BHIL also acquired 17.56% stake each in Bajaj General Insurance and Bajaj Life Insurance for Rs 16,331 cr.

Likely market impact

Strong headline numbers boosted by one-off BFS share sale. Underlying earnings growth healthy. Major insurance acquisition diversifies portfolio.